Enlivex Therapeutics Ltd. Ordinary Shares (par value NIS0.40 per share) Controlled Equity OfferingSM Sales AgreementEnlivex Therapeutics Ltd. • December 30th, 2022 • Pharmaceutical preparations • New York
Enlivex Therapeutics Ltd., a company organized under the laws of the State of Israel (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. and JMP Securities LLC (collectively, the “Agents”), as follows:
